Yubo International Biotech Limited
YBGJ
$0.053
$0.00367.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.50K | 25.80K | 454.30K | 455.70K | 608.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.50K | 25.80K | 454.30K | 455.70K | 608.80K |
| Cost of Revenue | 212.70K | 221.20K | 217.30K | 89.90K | 188.00K |
| Gross Profit | -209.20K | -195.40K | 237.00K | 365.80K | 420.80K |
| SG&A Expenses | 1.25M | 1.33M | 1.21M | 1.12M | 1.12M |
| Depreciation & Amortization | 183.30K | 256.00K | 253.50K | 227.00K | 190.10K |
| Other Operating Expenses | 341.70K | 368.90K | 296.20K | 306.20K | 311.90K |
| Total Operating Expenses | 1.99M | 2.17M | 1.97M | 1.74M | 1.81M |
| Operating Income | -1.98M | -2.15M | -1.52M | -1.29M | -1.20M |
| Income Before Tax | -1.98M | -2.15M | -1.52M | -1.29M | -1.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.98 | -2.15 | -1.52 | -1.29 | -1.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 206.40K | 143.20K | 103.00K | 32.20K | -- |
| Net Income | -1.78M | -2.00M | -1.42M | -1.26M | -1.20M |
| EBIT | -1.98M | -2.15M | -1.52M | -1.29M | -1.20M |
| EBITDA | -1.80M | -1.89M | -1.26M | -1.06M | -1.01M |
| EPS Basic | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 479.28M | 479.28M | 479.28M | 479.28M | 479.28M |
| Average Diluted Shares Outstanding | 479.28M | 479.28M | 479.28M | 479.28M | 479.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
